Successful use of afatinib after erlotinib-induced pneumonitis in a patient with epidermal growth factor receptor-mutant lung cancer Journal Article

   

Authors:	Jakubowski, C. D.; Plodkowski, A. J.; Chang, J. C.; Rekhtman, N.; Iqbal, A.; Paik, P. K.; Yu, H. A.
Article Title:	Successful use of afatinib after erlotinib-induced pneumonitis in a patient with epidermal growth factor receptor-mutant lung cancer
Keywords:	interstitial lung disease; drug toxicity; egfr-mutant lung cancer; egfr-tyrosine kinase inhibitors; drug-induced pneumonitis
Journal Title:	Clinical Lung Cancer
Volume:	18
Issue:	1
ISSN:	1525-7304
Publisher:	Elsevier Inc.
Date Published:	2017-01-01
Start Page:	e81
End Page:	e83
Language:	English
DOI:	10.1016/j.cllc.2016.10.001
PROVIDER:	scopus
PUBMED:	27863924
PMCID:	PMC5490243
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006827077&doi=10.1016%2fj.cllc.2016.10.001&partnerID=40&md5=1db669a99283d58e667379c2328b5487
Notes:	Article -- Export Date: 2 February 2017 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/104140